Use of botulinum toxin type A in children with cerebral palsy.
Nolan
Karen W
KW
Department of Physical Therapy, School of Health Science and Human Performance, Ithaca College-Rochester campus, 300 East River Road, Rochester, NY 14623, USA. knolan@ithaca.edu
Cole
Lynn L
LL
Liptak
Gregory S
GS
D019274:Botulinum Toxins, Type A / Q000494:pharmacology / Q000627:therapeutic use*; D002547:Cerebral Palsy / Q000188:drug therapy* / Q000503:physiopathology; D002648:Child; D020233:Gait Disorders, Neurologic / Q000188:drug therapy / Q000503:physiopathology; D006801:Humans; D009048:Motor Skills / Q000502:physiology; D009128:Muscle Spasticity / Q000188:drug therapy / Q000503:physiopathology; D009465:Neuromuscular Agents / Q000494:pharmacology / Q000627:therapeutic use*; D018579:Patient Selection; D026761:Physical Therapy Specialty; D024382:Professional Role; D016059:Range of Motion, Articular / Q000502:physiology
D009465:Neuromuscular Agents; D019274:Botulinum Toxins, Type A